Controlled by artificial intelligence (AI) software, a new nerve-stimulation device has helped three paralyzed patients to walk, cycle and swim again.
Digital health: The integration of data, biotech and digital technologies into services is transforming the way healthcare stakeholders approach research and patient care
Researchers have paired ultra-rapid DNA sequencing technology with cloud storage and computing, enabling them to discover undocumented genetic diseases.
Many diseases have a 'polygenic' underpinning, which can be helpful for giving us a personal estimate of our genetic risk for a certain disease or disorder.
New affordable technology means scientists can sequence genomes for all species, and the variation between species could uncover remarkable innovations.
A man in the US, suffering from heart disease became the first person ever to receive a transplant from a genetically modified pig heart this year.
Researchers forced the world’s only enclosed rainforest, Arizona's Biosphere 2, through a four-month-long controlled drought and recovery to learn more.
The biomanufacturing revolution is one of the most promising solutions to our biggest global problems, from plastic pollution to preventing pandemics.
Tulio de Oliveira, the scientist who alerted the WHO about the Omicron variant, proposes how to support countries to build genomic surveillance capabilities.
Data and its benefits are crucial when it comes to biotechnology but if they're not shared globally, we are missing out on making the most of the industry.
The new molecule, known as a biohybrid photocatalyst, can improve the yield of chemical reactions for generating pharmaceuticals and other useful compounds.
An ideal bioeconomy policy agenda needs to be established so that everyone can benefit from the latest advancements made in synthetic biology, expert says.
Plant biomass, or lignocellulose, is the most abundant renewable carbon source on the planet – but we are only just starting to grasp its potential in replacing fossil resources
There is potential for genetic engineering to bolster the response to climate change, but there are also risks and unknowns.
A US startup, Colossal Biosciences, has received $15 million in funding to bring woolly mammoths, who disappeared 4,000 years ago, back from extinction.